Shalby

INR
139.04
3.09 (2.27%)
BSENSE

Mar 25

BSE+NSE Vol: 3.57 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.57 lacs (103.19%) Volume

Shareholding (Dec 2025)

FII

4.47%

Held by 35 FIIs

DII

0.19%

Held by 1 DIIs

Promoter

74.33%

Who are in the management team of Shalby?

06-Jun-2025

As of March 2023, the management team of Shalby includes Vikram Shah (Chairman & Managing Director), Sushobhan Dasgupta (Vice Chairman), and several independent directors: Shyamal S Joshi, Umesh Menon, Ashok Bhatia, Tej Malhotra, Sujana Shah, and Vijay Kishanlal Kedia, along with Tushar Shah (Company Secretary & Compliance Officer).

As of March 2023, the management team of Shalby includes the following individuals:<BR><BR>1. Vikram Shah - Chairman & Managing Director<BR>2. Shyamal S Joshi - Independent Director<BR>3. Umesh Menon - Independent Director<BR>4. Ashok Bhatia - Independent Director<BR>5. Tej Malhotra - Independent Director<BR>6. Sujana Shah - Independent Director<BR>7. Tushar Shah - Company Secretary & Compliance Officer<BR>8. Sushobhan Dasgupta - Vice Chairman<BR>9. Vijay Kishanlal Kedia - Independent Director<BR><BR>This team comprises a mix of executive and independent directors, along with key compliance and governance roles.

View full answer

When is the next results date for Shalby?

06-Jun-2025

No Upcoming Board Meetings

Has Shalby declared dividend?

06-Jun-2025

Yes, Shalby Ltd. has declared a 12% dividend, amounting to ₹1.2 per share, with an ex-date of September 19, 2024. Despite recent negative returns in the short term, long-term performance shows positive trends, particularly over the last five years.

Shalby Ltd. has declared a 12% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 12%<BR>- Amount per share: 1.2<BR>- Ex-date: 19 Sep 24<BR><BR>Dividend Yield: 0.66%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, Shalby experienced a price return of -24.69%, with no dividend return, resulting in a total return of -24.69%.<BR><BR>Over the past year, the price return was -29.77%, with a dividend return of 0.43%, leading to a total return of -29.34%.<BR><BR>In the 2-year period, the price return was 28.62%, with a dividend return of 1.50%, resulting in a total return of 30.12%.<BR><BR>For the 3-year period, Shalby had a price return of 57.96%, a dividend return of 3.50%, culminating in a total return of 61.46%.<BR><BR>In the last 4 years, the price return was 6.68%, with a dividend return of 2.54%, leading to a total return of 9.22%.<BR><BR>Finally, over the 5-year period, Shalby achieved a price return of 167.0%, a dividend return of 7.00%, resulting in a total return of 174.0%.<BR><BR>Overall, while Shalby has declared a dividend, the recent total returns indicate significant volatility, particularly in the short term, with negative returns over the last year and six months. However, the longer-term returns show a more positive trend, especially over the 5-year period.

View full answer

Who are the peers of the Shalby?

03-Jun-2025

Shalby's peers include Max Healthcare, Apollo Hospitals, Fortis Health, Narayana Hrudaya, Global Health, GPT Healthcare, KMC Speciality, Asarfi Hospital, and Chandan Healthcare. In terms of performance, Shalby has the lowest 1-year return at -28.92%, while Asarfi Hospital leads with a 110.53% return.

Peers: The peers of Shalby are Max Healthcare, Apollo Hospitals, Fortis Health., Narayana Hrudaya, Global Health, GPT Healthcare, KMC Speciality, Asarfi Hospital, and Chandan Healthca.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, GPT Healthcare, and Chandan Healthca, while Good management risk is found at Apollo Hospitals, Narayana Hrudaya, Global Health, and Asarfi Hospital, and Average management risk is present at Fortis Health., Shalby, KMC Speciality, and the rest. For Growth, Excellent growth is seen at Max Healthcare and Chandan Healthca, Good growth at Apollo Hospitals, Narayana Hrudaya, and Fortis Health., while Below Average growth is noted at Shalby, GPT Healthcare, KMC Speciality, and the rest. In terms of Capital Structure, Excellent capital structure is held by Max Healthcare, Global Health, GPT Healthcare, KMC Speciality, and Chandan Healthca, while Average capital structure is found at Apollo Hospitals, and Good capital structure is observed at Fortis Health., Shalby, and Asarfi Hospital.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Asarfi Hospital at 110.53%, while Shalby has the lowest 1-year return at -28.92%. Shalby's return is significantly lower than all peers. Additionally, the peers with negative six-month returns include Shalby, GPT Healthcare, KMC Speciality, and Apollo Hospitals.

View full answer

What does Shalby do?

17-Jul-2025

Shalby Ltd. is a small-cap hospital company based in India, originally incorporated in 2004 and publicly listed since 2006. As of March 2025, it reported net sales of ₹2,649 Cr and a net loss of ₹110 Cr.

Overview:<BR>Shalby Ltd. operates in the hospital industry and is categorized as a small-cap company.<BR><BR>History:<BR>Shalby Ltd. was originally incorporated as 'Shalby Hospital Private Limited' in 2004. It transitioned to a public limited company in 2006, changing its name to 'Shalby Hospital Public Limited', then to 'Shalby Hospitals Limited', and finally to 'Shalby Limited' in 2008. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 2,649 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: -110 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: INR 2,096 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 345.00<BR>- Industry P/E: 59<BR>- Dividend Yield: 0.62%<BR>- Debt Equity: 0.35<BR>- Return on Equity: 0.63%<BR>- Price to Book: 2.10<BR><BR>Contact Details:<BR>- Address: Opp Karnawati Club, Sarkhej Gandhinagar Highway Ahmedabad Gujarat : 380015<BR>- Tel: 91-79-40203000<BR>- Email: companysecretary@shalby.in<BR>- Website: http://www.shalby.org

View full answer

Who are the top shareholders of the Shalby?

17-Jul-2025

The top shareholder of Shalby is the Shah Family Trust, led by Dr. Vikram Shah, with a 34.73% stake. Other notable shareholders include 38 foreign institutional investors with 5.2% and First Water Fund, the largest public shareholder, at 1.77%.

The top shareholders of Shalby include the Shah Family Trust, represented by Dr. Vikram Shah, who holds the largest stake at 34.73%. The company is primarily owned by its promoters, with no pledged promoter holdings. Additionally, there are 38 foreign institutional investors (FIIs) who collectively hold 5.2% of the shares. The highest public shareholder is First Water Fund, with a holding of 1.77%. Individual investors account for 11.2% of the total shareholding.

View full answer

How big is Shalby?

24-Jul-2025

As of 24th July, Shalby Ltd. has a market capitalization of 2,237.00 Cr, with recent net sales of 1,086.95 Cr and a net profit of 6.22 Cr. Shareholder's funds are 1,000.37 Cr and total assets amount to 1,607.53 Cr as of March 2024.

As of 24th July, <BR><BR>Shalby Ltd. has a market capitalization of 2,237.00 Cr, categorizing it as a Small Cap company. <BR><BR>For the latest four quarters, Shalby reported Net Sales of 1,086.95 Cr and a Net Profit of 6.22 Cr. <BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 1,000.37 Cr and Total Assets of 1,607.53 Cr.

View full answer

Is Shalby overvalued or undervalued?

09-Oct-2025

As of October 8, 2025, Shalby is considered very attractive and undervalued, with a PE ratio of -2742.37, a price-to-book value of 2.76, and strong long-term returns of 89.9% and 190.67% over three and five years, respectively, despite recent underperformance compared to peers like Apollo Hospitals and Max Healthcare.

As of 8 October 2025, the valuation grade for Shalby has moved from attractive to very attractive. The company is currently considered undervalued, particularly given its extreme PE ratio of -2742.37 and a price-to-book value of 2.76. Other notable ratios include an EV to EBITDA of 23.96 and a ROCE of 4.99%. <BR><BR>In comparison to its peers, Shalby stands out with a significantly lower PE ratio than Apollo Hospitals, which has a PE of 70.05, and Max Healthcare, which is at 92.31. Despite the negative sentiment reflected in the recent stock performance, where Shalby has underperformed the Sensex over the past week, its long-term returns over three and five years show a robust growth of 89.9% and 190.67%, respectively, reinforcing its undervaluation narrative.

View full answer

How has been the historical performance of Shalby?

01-Dec-2025

Shalby's historical performance shows strong revenue growth, with net sales increasing to 1,086.96 Cr by Mar'25, but rising expenditures led to a decline in operating profit and profit after tax, which fell to 1.92 Cr. Additionally, cash flow from operating activities turned negative in Mar'25, indicating potential liquidity issues.

Answer:<BR>The historical performance of Shalby shows significant growth in net sales and operating income over the years, with net sales increasing from 430.90 Cr in Mar'21 to 1,086.96 Cr in Mar'25. Total operating income followed a similar trend, reaching 1,086.96 Cr in Mar'25, up from 804.92 Cr in Mar'23. However, total expenditure also rose, climbing from 344.48 Cr in Mar'21 to 954.35 Cr in Mar'25, which impacted the operating profit, which decreased from 177.04 Cr in Mar'24 to 132.61 Cr in Mar'25. Profit before tax saw a decline from 128.19 Cr in Mar'24 to 55.73 Cr in Mar'25, leading to a profit after tax of only 1.92 Cr in Mar'25 compared to 83.50 Cr in Mar'24. The earnings per share dropped significantly from 7.83 in Mar'24 to 0.58 in Mar'25. On the balance sheet, total assets increased from 1,193.54 Cr in Mar'22 to 1,703.65 Cr in Mar'25, while total liabilities also rose from 1,193.54 Cr to 1,703.65 Cr in the same period. Cash flow from operating activities turned negative in Mar'25 at -4.00 Cr, contrasting with positive cash flows in previous years.<BR><BR>Breakdown:<BR>Shalby's financial performance has shown a robust increase in net sales, which rose from 430.90 Cr in Mar'21 to 1,086.96 Cr in Mar'25, indicating strong revenue growth. Total operating income mirrored this growth, reaching 1,086.96 Cr in Mar'25. However, total expenditure surged to 954.35 Cr in Mar'25, leading to a decline in operating profit from 177.04 Cr in Mar'24 to 132.61 Cr in Mar'25. This decline was further reflected in profit before tax, which fell from 128.19 Cr in Mar'24 to 55.73 Cr in Mar'25, resulting in a profit after tax of just 1.92 Cr in Mar'25. The earnings per share also saw a drastic drop from 7.83 in Mar'24 to 0.58 in Mar'25. On the balance sheet, total assets increased significantly to 1,703.65 Cr in Mar'25, while total liabilities rose correspondingly, indicating a growing debt load. Cash flow from operating activities turned negative in Mar'25, contrasting with positive cash flows in prior years, highlighting potential liquidity challenges.

View full answer

Is Shalby technically bullish or bearish?

02-Dec-2025

As of December 1, 2025, the market trend has shifted to mildly bearish, supported by bearish MACD readings, Bollinger Bands, and Dow Theory, despite some daily moving averages indicating mild bullishness.

As of 1 December 2025, the technical trend has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by weekly and monthly MACD readings indicating bearish momentum, along with Bollinger Bands and KST both signaling bearish conditions. The Dow Theory also supports a mildly bearish outlook on both weekly and monthly time frames. Although daily moving averages show a mildly bullish signal, the overall technical indicators suggest a bearish sentiment prevailing in the market.

View full answer

Are Shalby Ltd. latest results good or bad?

12-Feb-2026

Shalby Ltd.'s latest Q3 FY26 results are concerning, showing a 78.90% decline in net profit and a 4.66% drop in revenue, marking two consecutive quarters of revenue decline. The company's performance is significantly below industry standards, indicating serious operational challenges and poor financial health.

Shalby Ltd.'s latest results for Q3 FY26 indicate a concerning performance. The company reported a net profit of ₹1.77 crore, which represents a dramatic decline of 78.90% quarter-on-quarter. Revenue also decreased by 4.66% to ₹272.13 crore, marking the second consecutive quarter of revenue decline. <BR><BR>The operating margin, excluding other income, fell significantly to 11.12% from 14.58% in the previous quarter, reflecting rising cost pressures and operational inefficiencies. Additionally, the profit before tax was just ₹9.23 crore, down from ₹19.07 crore in Q2 FY26, and an unusually high tax rate of 86.13% severely impacted net profitability.<BR><BR>In the context of the broader hospital sector, which has been experiencing robust growth, Shalby's underperformance stands out. The stock has also significantly lagged behind its peers, with a return of negative 17.25% over the past year compared to the hospital sector's positive 25.33% return.<BR><BR>Overall, the results reflect serious operational challenges and a deterioration in financial health, suggesting that the latest performance is indeed bad for Shalby Ltd.

View full answer

Should I buy, sell or hold Shalby Ltd.?

13-Feb-2026

Why is Shalby Ltd. falling/rising?

18-Mar-2026

As of 17-Mar, Shalby Ltd. is facing a decline in its stock price, currently at Rs 139.50, with a year-to-date drop of 31.40%. This decline is attributed to poor performance, waning investor interest, and a significant profit reduction of 76.2% over the past year.

As of 17-Mar, Shalby Ltd. is experiencing a decline in its stock price, currently at Rs 139.50, reflecting a change of -0.55 (-0.39%). This downward trend is supported by several factors. Over the past week, the stock has fallen by 4.62%, and in the last month, it has decreased by 12.68%. Year-to-date, the stock has dropped significantly by 31.40%, which is notably worse than the Sensex's decline of 10.74% during the same period. <BR><BR>The stock has been underperforming in comparison to its sector, with a performance today that is 0.94% lower than its peers. Additionally, it has seen a consecutive decline over the last three days, accumulating a total drop of 5.55%. The stock is also trading below its moving averages across various time frames, indicating a bearish trend.<BR><BR>Investor participation appears to be waning, as evidenced by a significant drop in delivery volume, which fell by 44.6% compared to the five-day average. Furthermore, the stock is close to its 52-week low, just 1.79% above that threshold, which may signal a lack of confidence among investors.<BR><BR>While there are some positive factors, such as a strong ability to service debt and healthy long-term growth in net sales and operating profit, these have not been sufficient to counterbalance the negative sentiment surrounding the stock. The company has reported a substantial profit decline of 76.2% over the past year, and domestic mutual funds hold no stake in the company, which could indicate a lack of confidence in its future performance.<BR><BR>Overall, the combination of poor recent performance, declining investor interest, and significant profit reductions contributes to the falling stock price of Shalby Ltd.

View full answer

Why is Shalby Ltd. falling/rising?

19-Mar-2026

As of 18-Mar, Shalby Ltd. is seeing a stock price increase to Rs 144.60, up 4.18% after a trend reversal. However, it has a -28.02% return over the past year and faces long-term challenges, including low investor confidence and declining delivery volume.

As of 18-Mar, Shalby Ltd. is experiencing a rise in its stock price, currently at Rs 144.60, reflecting an increase of Rs 5.8 or 4.18%. This upward movement follows a trend reversal, as the stock has gained after three consecutive days of decline. Additionally, it has outperformed its sector by 2.88% today and reached an intraday high of Rs 145.35, indicating positive momentum.<BR><BR>Despite this recent rise, the stock has faced significant challenges over the longer term. Over the past year, it has generated a return of -28.02%, with profits falling by -76.2%. Furthermore, the stock is trading below its moving averages across various time frames, suggesting a bearish trend overall. The delivery volume has also decreased significantly, falling by -63.62% against the five-day average, indicating a decline in investor participation.<BR><BR>On a positive note, Shalby Ltd. has a strong ability to service its debt, with a low Debt to EBITDA ratio of 1.18 times, and it has shown healthy long-term growth in net sales and operating profit. However, the overall sentiment remains cautious, particularly as domestic mutual funds hold no stake in the company, which may reflect a lack of confidence in its valuation or business prospects.<BR><BR>In summary, while Shalby Ltd. is currently rising in price due to a short-term trend reversal and sector outperformance, it continues to face significant long-term challenges that could affect its stability and investor confidence.

View full answer

Why is Shalby Ltd. falling/rising?

20-Mar-2026

As of 19-Mar, Shalby Ltd. is facing a stock price decline to Rs 138.75, down 4.41%, primarily due to significant underperformance against the Sensex and concerning financial metrics, including a 76.2% drop in profits over the past year. The stock's bearish trend is further indicated by low investor confidence and reduced participation.

As of 19-Mar, Shalby Ltd. is experiencing a decline in its stock price, currently at Rs 138.75, which represents a decrease of Rs 6.4 or 4.41%. This downward movement can be attributed to several factors highlighted in the provided data. <BR><BR>Firstly, the stock has underperformed significantly compared to the benchmark Sensex, with a 1-week decline of 6.06% against the Sensex's 2.40% drop, and a 1-month decline of 11.48% compared to the Sensex's 10.05%. Year-to-date, Shalby Ltd. has fallen by 31.77%, while the Sensex has only decreased by 12.92%. This trend indicates a consistent underperformance relative to the broader market.<BR><BR>Additionally, the stock is trading close to its 52-week low, just 1.26% away from Rs 137, and it opened with a loss of 2.07% today. The intraday low reached Rs 138, marking a 4.93% decline. The weighted average price suggests that more volume has been traded near this low price, indicating a lack of investor confidence. Furthermore, Shalby Ltd. is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a bearish trend.<BR><BR>Investor participation has also decreased, with delivery volume dropping by 25.78% compared to the 5-day average, suggesting reduced interest in the stock. The overall sector, Hospital & Healthcare Services, has fallen by 2.8%, contributing to the negative sentiment surrounding Shalby Ltd.<BR><BR>While there are some positive factors, such as a strong ability to service debt and healthy long-term growth in net sales and operating profit, these have not been sufficient to offset the negative performance indicators. The company's profits have fallen by 76.2% over the past year, and it has generated a return of -31.65%, which further diminishes investor confidence. The flat results reported in December, along with the highest debt-equity ratio at 0.53 times and the lowest return on capital employed at 6.10%, also raise concerns about the company's financial health.<BR><BR>In summary, the combination of poor stock performance relative to benchmarks, declining investor participation, and concerning financial metrics has led to the falling stock price of Shalby Ltd.

View full answer

Why is Shalby Ltd. falling/rising?

21-Mar-2026

As of 20-Mar, Shalby Ltd.'s stock price is rising to Rs 139.75, despite a -31.26% return over the past year. The stock shows strong debt servicing ability and healthy long-term growth, but remains below moving averages and has declining investor participation.

As of 20-Mar, Shalby Ltd.'s stock price is rising, currently at Rs 139.75, reflecting an increase of 1.0 (0.72%). This uptick comes despite the stock's overall negative performance in the past year, where it has generated a return of -31.26%. The stock has also underperformed compared to the Sensex, which has only declined by -2.38% over the same period.<BR><BR>Today's performance shows that the stock reached an intraday high of Rs 143.5, indicating some positive trading activity. However, it is important to note that the stock is still trading below its moving averages across various time frames, which suggests a general downward trend. Additionally, the delivery volume has decreased by -20.91% against the 5-day average, indicating falling investor participation.<BR><BR>On a more positive note, Shalby Ltd. has a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 1.18 times. The company has also shown healthy long-term growth, with net sales growing at an annual rate of 23.17% and operating profit at 25.38%. Despite these strengths, the stock's valuation remains attractive, trading at a discount compared to its peers, which may contribute to the current rise in price.<BR><BR>In summary, while Shalby Ltd. is experiencing a rise in its stock price today, this is juxtaposed against a backdrop of significant long-term underperformance and declining investor interest.

View full answer

Why is Shalby Ltd. falling/rising?

24-Mar-2026

As of 23-Mar, Shalby Ltd.'s stock price is at Rs. 130.85, reflecting a 6.5% decline and reaching a new 52-week low. The stock has underperformed its sector and shows significant downward pressure, with reduced investor participation and high volatility.

As of 23-Mar, Shalby Ltd.'s stock price is falling, currently at Rs. 130.85, which represents a decrease of Rs. 9.1 or 6.5%. This decline is reflected in the stock's performance over various periods, showing a 1-week drop of 6.57%, a 1-month decline of 14.67%, and a year-to-date decrease of 35.65%. Additionally, the stock has reached a new 52-week low today, indicating significant downward pressure.<BR><BR>The stock opened with a loss of 2.04% today and touched an intraday low of Rs. 130.85, confirming the bearish trend. It has underperformed its sector by 4.1% and has been characterized by high volatility, with an intraday volatility of 5.18%. Furthermore, Shalby Ltd. is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a weak performance relative to historical trends.<BR><BR>Investor participation has also declined, with delivery volume dropping by 49.82% compared to the 5-day average, suggesting reduced interest in the stock. The broader Hospital & Healthcare Services sector has also seen a decline of 2.37%, which may contribute to the negative sentiment surrounding Shalby Ltd. Overall, these factors collectively indicate that the stock is experiencing a downward trend.

View full answer

Why is Shalby Ltd. falling/rising?

25-Mar-2026

As of 24-Mar, Shalby Ltd.'s stock price is at 135.05, showing a 2.74% increase due to positive trading momentum and increased investor interest, despite a challenging year with a -33.14% return. The stock's strong fundamentals and relative outperformance in its sector contribute to a favorable short-term outlook.

As of 24-Mar, Shalby Ltd.'s stock price is rising, currently at 135.05, reflecting a change of 3.6 or 2.74% increase. This upward movement can be attributed to several factors. Firstly, the stock opened with a gain of 2.43% today and reached an intraday high of Rs 136.9, indicating positive trading momentum. Additionally, the stock has outperformed its sector by 0.39%, suggesting a relative strength compared to its peers in the Hospital & Healthcare Services sector, which gained by 2.48%.<BR><BR>Moreover, there has been a notable increase in investor participation, with delivery volume rising by 41.66% against the 5-day average, indicating growing interest in the stock. Despite trading lower than its moving averages, the company's strong fundamentals, such as a low Debt to EBITDA ratio of 1.18 times and healthy long-term growth in net sales and operating profit, contribute to a favorable outlook. <BR><BR>However, it is important to note that the stock has faced significant challenges over the past year, generating a return of -33.14% and experiencing a decline in profits by -76.2%. Despite these issues, the current rise in stock price reflects a short-term positive sentiment among investors, likely driven by today's performance and increased trading activity.

View full answer

Why is Shalby Ltd. falling/rising?

26-Mar-2026

As of 25-Mar, Shalby Ltd.'s stock price is rising to Rs 139.00, up 1.79%, driven by increased investor interest and positive trading momentum. However, it has a year-to-date decline of 31.64%, indicating long-term underperformance despite the recent gains.

As of 25-Mar, Shalby Ltd.'s stock price is rising, currently at Rs 139.00, reflecting a change of 2.45 (1.79%) upward. This increase can be attributed to a few key factors. Firstly, the stock has been gaining for the last two days, with a total return of 5.74% during this period. Additionally, the stock reached an intraday high of Rs 141.1, indicating positive trading momentum.<BR><BR>Investor participation has also increased, as evidenced by a significant rise in delivery volume, which was up by 52.66% compared to the 5-day average. This suggests heightened interest from investors, contributing to the stock's upward movement. Furthermore, the broader sector of Hospital & Healthcare Services has performed well, gaining 2.27%, which may have positively influenced Shalby Ltd.'s stock price.<BR><BR>Despite these positive indicators, it is important to note that the stock has underperformed in the longer term, with a year-to-date decline of 31.64% and a one-year return of -29.46%. However, the current rise in price appears to be driven by short-term trading dynamics and increased investor interest rather than a fundamental turnaround in the company's long-term performance.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Dec 25

  • PBT LESS OI(Q) At Rs 2.00 cr has Fallen at -71.14%
  • ROCE(HY) Lowest at 6.10%
  • DEBT-EQUITY RATIO(HY) Highest at 0.53 times
2

Despite the size of the company, domestic mutual funds hold only 0% of the company

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 1,488 Cr (Small Cap)

stock-summary
P/E

186.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.43

stock-summary
Return on Equity

0.45%

stock-summary
Price to Book

1.46

Revenue and Profits:
Net Sales:
272 Cr
(Quarterly Results - Dec 2025)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-30.93%
0%
-30.93%
6 Months
-44.6%
0%
-44.6%
1 Year
-29.89%
0%
-29.89%
2 Years
-42.77%
0.45%
-42.32%
3 Years
15.05%
1.64%
16.69%
4 Years
11.32%
2.58%
13.9%
5 Years
41.3%
3.68%
44.98%

Latest dividend: 1.2 per share ex-dividend date: Sep-19-2024

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Shalby Limited - Updates

18-Nov-2019 | Source : NSE

Shalby Limited has informed the Exchange regarding 'Shalby Conferred with Medical Value Travel Specialist Hospital Award in the category Orthopaedics (Joint Replacement)'.

Shalby Limited - Updates

13-Nov-2019 | Source : NSE

Shalby Limited has informed the Exchange regarding 'Newspaper publication of Financial Results together with Statement of utilization and deviation/variation of net issue proceeds for Q2 FY2020'.

Shalby Limited - Credit Rating

22-Oct-2019 | Source : NSE

Shalby Limited has informed the Exchange regarding Credit Rating

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Shalby Ltd. has declared 12% dividend, ex-date: 19 Sep 24

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
23.17%
EBIT Growth (5y)
25.38%
EBIT to Interest (avg)
8.36
Debt to EBITDA (avg)
1.94
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.68
Tax Ratio
91.97%
Dividend Payout Ratio
15.33%
Pledged Shares
0
Institutional Holding
4.66%
ROCE (avg)
8.10%
ROE (avg)
5.51%

Valuation key factors

Factor
Value
P/E Ratio
186
Industry P/E
55
Price to Book Value
1.50
EV to EBIT
29.01
EV to EBITDA
14.37
EV to Capital Employed
1.35
EV to Sales
1.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.00%
ROE (Latest)
0.45%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 35 FIIs (4.47%)

Promoter with highest holding

Shah Family Trust Throuh Dr. Vikram Shah, Trustee (34.79%)

Highest Public shareholder

First Water Fund (1.28%)

Individual Investors Holdings

11.72%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -1.27% vs 27.58% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 197.79% vs -109.49% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "272.13",
          "val2": "275.63",
          "chgp": "-1.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.26",
          "val2": "33.91",
          "chgp": "-10.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "10.64",
          "val2": "10.66",
          "chgp": "-0.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.77",
          "val2": "-1.81",
          "chgp": "197.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.12%",
          "val2": "12.30%",
          "chgp": "-1.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 6.48% vs 15.41% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -9.13% vs -60.65% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "581.86",
          "val2": "546.43",
          "chgp": "6.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "83.15",
          "val2": "77.86",
          "chgp": "6.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.02",
          "val2": "17.39",
          "chgp": "9.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "17.31",
          "val2": "19.05",
          "chgp": "-9.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.29%",
          "val2": "14.25%",
          "chgp": "0.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 3.88% vs 19.22% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 10.67% vs -74.45% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "853.99",
          "val2": "822.06",
          "chgp": "3.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "113.41",
          "val2": "111.77",
          "chgp": "1.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "29.66",
          "val2": "28.05",
          "chgp": "5.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "19.08",
          "val2": "17.24",
          "chgp": "10.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.28%",
          "val2": "13.60%",
          "chgp": "-0.32%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 16.41% vs 16.01% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -92.60% vs 24.19% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,086.96",
          "val2": "933.75",
          "chgp": "16.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "132.61",
          "val2": "177.04",
          "chgp": "-25.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "38.71",
          "val2": "16.03",
          "chgp": "141.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.22",
          "val2": "84.08",
          "chgp": "-92.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.20%",
          "val2": "18.96%",
          "chgp": "-6.76%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
272.13
275.63
-1.27%
Operating Profit (PBDIT) excl Other Income
30.26
33.91
-10.76%
Interest
10.64
10.66
-0.19%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.77
-1.81
197.79%
Operating Profit Margin (Excl OI)
11.12%
12.30%
-1.18%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is -1.27% vs 27.58% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 197.79% vs -109.49% in Dec 2024

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
581.86
546.43
6.48%
Operating Profit (PBDIT) excl Other Income
83.15
77.86
6.79%
Interest
19.02
17.39
9.37%
Exceptional Items
0.00
0.00
Consolidate Net Profit
17.31
19.05
-9.13%
Operating Profit Margin (Excl OI)
14.29%
14.25%
0.04%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 6.48% vs 15.41% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -9.13% vs -60.65% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
853.99
822.06
3.88%
Operating Profit (PBDIT) excl Other Income
113.41
111.77
1.47%
Interest
29.66
28.05
5.74%
Exceptional Items
0.00
0.00
Consolidate Net Profit
19.08
17.24
10.67%
Operating Profit Margin (Excl OI)
13.28%
13.60%
-0.32%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 3.88% vs 19.22% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 10.67% vs -74.45% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
1,086.96
933.75
16.41%
Operating Profit (PBDIT) excl Other Income
132.61
177.04
-25.10%
Interest
38.71
16.03
141.48%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6.22
84.08
-92.60%
Operating Profit Margin (Excl OI)
12.20%
18.96%
-6.76%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 16.41% vs 16.01% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -92.60% vs 24.19% in Mar 2024

stock-summaryCompany CV
About Shalby Ltd. stock-summary
stock-summary
Shalby Ltd.
Small Cap
Hospital
Shalby Ltd was originally incorporated as a Private Limited Company with the name 'Shalby Hospital Private Limited' on August 30, 2004. Subsequently, the Company was converted to a Public Limited Company and the name was changed to 'Shalby Hospital Public Limited' on May 15, 2006. Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008.
Company Coordinates stock-summary
Company Details
Opp Karnawati Club, Sarkhej Gandhinagar Highway Ahmedabad Gujarat : 380015
stock-summary
Tel: 91-79-40203000
stock-summary
companysecretary@shalby.in
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad